Nedaplatin or Oxaliplatin Combined with Paclitaxel and Docetaxel as First-Line Treatment for Patients with Advanced Non-Small Cell Lung Cancer

BACKGROUND: Both nedaplatin and oxaliplatin combined with paclitaxel or docetaxel have demonstrated potent activity in advanced non-small cell lung cancer (NSCLC) patients, but there is no study comparing the difference between these 2 chemotherapy regimens. The aim of this study was to evaluate and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Keqian, Qin, Hong, Pan, Feng, Liu, Enqiang, Liang, Houjie, Ruan, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285922/
https://www.ncbi.nlm.nih.gov/pubmed/25548985
http://dx.doi.org/10.12659/MSM.891318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285922/
https://www.ncbi.nlm.nih.gov/pubmed/25548985
http://dx.doi.org/10.12659/MSM.891318

Ejemplares similares